Nair S K, Elbaum D, Christianson D W
Department of Chemistry, University of Pennsylvania, Philadelphia 19104-6323, USA.
J Biol Chem. 1996 Jan 12;271(2):1003-7. doi: 10.1074/jbc.271.2.1003.
The three-dimensional structure of human carbonic anhydrase II (CAII) complexed with the sulfonamide fluorophore 5-dimethylamino-1-naphthalene sulfonamide (dansylamide) has been determined to 2.1-A resolution by x-ray crystallographic methods. Unlike other arylsulfonamide inhibitors of CAII, the naphthyl ring of dansylamide binds in a hydrophobic pocket in the active site, making van der Waals contacts with Val-121, Phe-131, Val-143, Leu-198, and Trp-209. Interestingly, a conformational change of Leu-198 is required to accommodate dansylamide binding, which rationalizes the enhanced dansylamide affinity measured for certain Leu-198 variants (Nair, S. K., Krebs, J.F., Christianson, D. W., and Fierke, C. A. (1995) Biochemistry 34, 3981-3989). Modeling studies indicate that a second binding mode, in which the fused aromatic ring is rotated out of the hydrophobic pocket, is sterically feasible. Both experimentally observed and modeled binding modes have implications for new leads in the design of avid CAII inhibitors. Finally, the structure of the CAII-dansylamide complex has implications for its exploitation in zinc biosensor applications, and possible routes toward the optimization of fluorophore design are considered on the basis on this structure.
通过X射线晶体学方法,已确定与磺酰胺荧光团5-二甲基氨基-1-萘磺酰胺(丹磺酰胺)复合的人碳酸酐酶II(CAII)的三维结构,分辨率达到2.1埃。与CAII的其他芳基磺酰胺抑制剂不同,丹磺酰胺的萘环结合在活性位点的疏水口袋中,与Val-121、Phe-131、Val-143、Leu-198和Trp-209形成范德华接触。有趣的是,需要Leu-198发生构象变化以适应丹磺酰胺的结合,这解释了对某些Leu-198变体测得的丹磺酰胺亲和力增强的原因(奈尔,S.K.,克雷布斯,J.F.,克里斯蒂安森,D.W.,和菲克,C.A.(1995年)《生物化学》34,3981 - 3989)。模型研究表明,第二种结合模式在空间上是可行的,在这种模式中,稠合芳环从疏水口袋中旋转出来。实验观察到的和模型化的结合模式都对设计高亲和力CAII抑制剂的新先导化合物有启示。最后,CAII - 丹磺酰胺复合物的结构对其在锌生物传感器应用中的开发有启示,并且基于该结构考虑了优化荧光团设计的可能途径。